{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-072842","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.614728+00:00","generated_at":"2026-05-17T17:46:32.094854+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SS Innovations Q2 revenue up 122% to $10M; net loss narrows to $0.3M","bullets":["Revenue of $10.0M, up 121.8% YoY; gross margin expanded to 59.1% from 31.9%.","Net loss of $0.3M vs. $4.1M loss in Q2 2024; EPS $(0.00) per diluted share.","SSi Mantra installations totaled 23 in quarter, up 130% YoY; cumulative base 105 in 7 countries.","Cash and cash equivalents $11.4M; long-term debt $0.","Plans to submit 510(k) for SSi Mantra 3 to FDA by end of September 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-072842","json":"https://secwatch.observer/filing/0001213900-25-072842.json","markdown":"https://secwatch.observer/filing/0001213900-25-072842.md","text":"https://secwatch.observer/filing/0001213900-25-072842.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390025072842/0001213900-25-072842-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390025072842/ea0252155-8k_ssinnov.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:46:32.094854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}